CD8A and neoplasm: Bmal1 deficiency in DCs and CD8+ T cells has been shown to impair immune cell migration, antigen presentation, cytokine/chemokine production, and responses to pathogens, tumor engraftment, and vaccination (12–16, 32, 33).